OTC Healthcare in Japan
Euromonitor International's OTC Healthcare in Japan market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 108 | Publication date: Sep 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Ongoing growth due to demographic and lifestyle change
2006 saw continuing positive growth in current value sales of OTC healthcare. This was due to demographic changes, with an ageing population and lower birth rate, in addition to cultural changes, as self-medication became a key word for many manufacturers and retailers in OTC healthcare. Also Japan is famously stressful for its inhabitants, which boosted sales, especially for calming and sleeping products.
Self-medication brings both opportunity and threat
The government encouraged self-medication towards the end of the review period, aiming to reduce medical costs for an ageing society. People began to care about their body more, aiming to prevent illness by living healthily. Consequently, the business environment in OTC healthcare became more competitive, with new entries from other industries such as food and cosmetics.
In particular, middle-aged men and women over 40s are interested in self-medication, particularly focusing on their metabolism and anti-ageing strategies in 2006. Various scientific studies showed the risks of obesity, especially among middle-aged men, and manufacturers consequently began to produce new drugs in digestive remedies. Secondly, women tried to keep themselves looking young and sought anti-ageing products such as in vitamin and dietary supplements and medicated skin care.
Changes in tax and sales network
Changes in regulations and tax have a big influence on OTC healthcare. In 2006, a new definition of the scope of OTC healthcare and its sales network was created, which will come into effect from 2009. With these amendments, OTC healthcare distribution will be expanded from pharmacies/drugstores to supermarkets/hypermarkets and convenience stores. Both manufacturers and retailers see this as a chance to boost value sales and volume. Also, the government disclosed plans to raise taxes on cigarettes in 2005, which was implemented in 2006. This boosted sales of NRT smoking cessation aids.
Shift towards nuclear family creates innovative packaging
Japan saw an increasing number of nuclear families during the review period. Manufacturers thus started to offer small pack sizes for smaller household. In addition, consumers increasingly began to take medicine away-from-home, at work and school. Consequently, more fashionable and portable packaging is sought by Japanese consumers.
Acquisiton is key to future growth
With lifestyle changes and increased competition from other industries and foreign players, manufacturers focused on mergers and acquisitions and the opportunity to enhance operational synergies. By doing so, companies aim not only to achieve efficient management and production by cutting costs but also to expand sales with new product developments while sharing knowledge and technology with each other. Retailers began to follow the same strategy to maintain their leading positions by acquiring larger outlet volume. This trend will increase during the forecast period, as the retail environment becomes increasingly competitive as a result of legislation changes expanding OTC healthcare distribution from 2009.
Vitamins and dietary supplements to dominate projected sales
Forecasts are comparatively optimistic, with sales expected to increase by a CAGR of 2% between 2006-2011. In terms of actual value, the overwhelming bulk of gains will be attributable to vitamins and dietary supplements, thanks to the country's ageing population. Further dynamic growth is expected in calming and sleeping products and NRT smoking cessation aids.
Table of contents
OTC HEALTHCARE IN JAPAN : MARKET INSIGHT
EXECUTIVE SUMMARY
Ongoing growth due to demographic and lifestyle change
Self-medication brings both opportunity and threat
Changes in tax and sales network
Shift towards nuclear family creates innovative packaging
Acquisiton is key to future growth
Vitamins and dietary supplements to dominate projected sales
KEY TRENDS AND DEVELOPMENTS
Demographic change creates demand for anti-ageing products
Legislation eases regulations on OTC sales
Self-medication to prevent illness needs marketing
Increased merger and acquisition activity in manufacturers and retailers
Increasing number of nuclear families and single-person households exerts a growing influence
MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Penetration of Private Label by Sector 2002-2006
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Generics
Consumer expenditure on health goods and medical services
Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
LOCAL COMPANY PROFILES - JAPAN
EISAI CO LTD - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Eisai Co Ltd: Key Facts
Summary 2 Eisai Co Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 3 Eisai Co Ltd: Competitive Position 2006
HISAMITSU PHARMACEUTICAL CO INC - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 4 Hisamitsu Pharmaceutical Co Inc: Key Facts
Summary 5 Hisamitsu Pharmaceutical Co Inc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 6 Hisamitsu Pharmaceutical Co Inc: Competitive Position 2006
LION CORP - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Lion Corp: Key Facts
Summary 8 Lion Corp: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 9 Lion Corp: Competitive Position 2006
MIKI CORP - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 10 Miki Corp: Key Facts
Summary 11 Miki Corp: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 12 Miki Corp: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 13 Miki Corp: Competitive Position 2006
ROHTO PHARMACEUTICAL CO LTD - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 14 Rohto Pharmaceutical Co Ltd: Key Facts
Summary 15 Rohto Pharmaceutical Co Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 16 Rohto Pharmaceutical Co Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 17 Rohto Pharmaceutical Co Ltd: Competitive Position 2006
SANKYO CO LTD - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 18 Sankyo Co Ltd: Key Facts
Summary 19 Sankyo Co Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 20 Sankyo Co Ltd: Competitive Position 2006
SATO PHARMACEUTICAL CO LTD - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 21 Sato Pharmaceutical Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
Summary 22 Sato Pharmaceutical Co Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 23 Sato Pharmaceutical Co Ltd: Competitive Position 2006
SSP CO LTD - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 24 SSP Co Ltd: Key Facts
Summary 25 SSP Co Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 26 SSP Co Ltd: Competitive Position 2006
TAISHO PHARMACEUTICAL CO LTD - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 27 Taisho Pharmaceutical Co Ltd: Key Facts
Summary 28 Taisho Pharmaceutical Co Ltd]: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 29 Taisho Pharmaceutical Co Ltd: Competitive Position 2006
TAKEDA CHEMICAL INDUSTRIES LTD - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 30 Takeda Chemical Industries Ltd: Key Facts
Summary 31 Takeda Chemical Industries Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 32 Takeda Chemical Industries Ltd: Competitive Position 2006
ANALGESICS IN JAPAN
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Analgesics by Subsector: Value 2001-2006
Table 13 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 14 Herbal vs Standard Topical Analgesics 2001/2006
Table 15 Analgesics Company Shares by Retail Value 2002-2006
Table 16 Analgesics Brand Shares by Retail Value 2003-2006
Table 17 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN JAPAN
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
Table 21 Sales of Decongestants by Type: Value 2001-2006
Table 22 Sales of Decongestants by Type: % Value Growth 2001-2006
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
DIGESTIVE REMEDIES IN JAPAN
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 30 Sales of Digestive Remedies by Subsector: Value 2001-2006
Table 31 Sales of Digestive Remedies by Subsector: % Value Growth 2001-2006
Table 32 Herbal vs Standard Digestive Remedies 2001/2006
Table 33 Digestive Remedies Company Shares by Retail Value 2002-2006
Table 34 Digestive Remedies Brand Shares by Retail Value 2003-2006
Table 35 Forecast Sales of Digestive Remedies by Subsector: Value 2006-2011
Table 36 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2006-2011
MEDICATED SKIN CARE IN JAPAN
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 37 Sales of Medicated Skin Care by Subsector: Value 2001-2006
Table 38 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
Table 39 Herbal vs Standard Medicated Skin Care 2001/2006
Table 40 Medicated Skin Care Company Shares by Retail Value 2002-2006
Table 41 Medicated Skin Care Brand Shares by Retail Value 2003-2006
Table 42 Acne Treatments Brand Shares by Retail Value 2003-2006
Table 43 Hair Loss Treatments Brand Shares by Retail Value 2003-2006
Table 44 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
Table 45 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011
VITAMINS AND DIETARY SUPPLEMENTS IN JAPAN
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 46 Sales of Vitamins and Dietary Supplements by Subsector: Value 2001-2006
Table 47 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2001-2006
Table 48 Sales of Vitamins by Type: Value 2001-2006
Table 49 Sales of Vitamins by Type: % Value Growth 2001-2006
Table 50 Vitamins and Dietary Supplements Company Shares by Retail Value 2002-2006
Table 51 Vitamins and Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 52 Vitamins Brand Shares by Retail Value 2003-2006
Table 53 Sales of Dietary Supplements by Type: Value 2001-2006
Table 54 Sales of Dietary Supplements by Type: % Value Growth 2001-2006
Table 55 Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 56 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2006-2011
Table 57 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2006-2011
NRT SMOKING CESSATION AIDS IN JAPAN
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 58 Number of Smokers by Gender 2001-2006
Table 59 Sales of Smoking Cessation Aids by Subsector: Value 2001-2006
Table 60 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2001-2006
Table 61 Smoking Cessation Aids Company Shares by Retail Value 2002-2006
Table 62 Smoking Cessation Aids Brand Shares by Retail Value 2003-2006
Table 63 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2006-2011
Table 64 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2006-2011
EYE CARE IN JAPAN
SECTOR DATA
Table 65 Sales of Eye Care by Subsector: Value 2001-2006
Table 66 Sales of Eye Care by Subsector: % Value Growth 2001-2006
Table 67 Eye Care Company Shares by Retail Value 2002-2006
Table 68 Eye Care Brand Shares by Retail Value 2003-2006
Table 69 Forecast Sales of Eye Care by Subsector: Value 2006-2011
Table 70 Forecast Sales of Eye Care by Subsector: % Value Growth 2006-2011
EAR CARE IN JAPAN
ADULT MOUTHCARE IN JAPAN
CALMING AND SLEEPING PRODUCTS IN JAPAN
WOUND TREATMENTS IN JAPAN
SECTOR DATA
Table 71 Sales of Wound Treatments by Subsector: Value 2001-2006
Table 72 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
Table 73 Wound Treatments Company Shares by Retail Value 2002-2006
Table 74 Wound Treatments Brand Shares by Retail Value 2003-2006
Table 75 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
Table 76 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011
EMERGENCY CONTRACEPTION IN JAPAN